What You Need to Know About Cutaneous Melanoma Staging
What You Need to Know About Cutaneous Melanoma Staging
The Big Picture
Understanding how doctors stage melanoma can give you insights into treatment options and prognosis. This article breaks down the key points of the TNM staging system for cutaneous melanoma.
Contents
What's the TNM Staging System?
The TNM system is a method used by doctors to describe the size and spread of cancer. 'T' stands for the size of the primary tumor, 'N' indicates if cancer has spread to nearby lymph nodes, and 'M' shows whether it has metastasized to other parts of the body. For melanoma, each of these letters is followed by a number to give more detail about how advanced the cancer is.
Changes in the Latest Edition
The eighth edition of the AJCC staging system introduced a few changes. One of the major updates is the removal of the mitotic rate as a staging criterion for T1 tumors, although it remains an important factor for prognosis. Another change is in how the thickness of the tumor is measured; now it's rounded to the nearest 0.1 mm instead of 0.01 mm.
Why Staging Matters
Staging helps doctors decide the best treatment plan and determine the prognosis. Different stages correspond to different survival rates and treatment options. For example, early-stage melanoma might only require surgery, while later stages could involve more complex treatments like immunotherapy.
FAQs
How is melanoma staged?
Melanoma is staged using the TNM system, which looks at the tumor size, lymph node involvement, and metastasis.
What's new in the eighth edition?
The eighth edition removes mitotic rate as a criterion for T1 tumors and changes how tumor thickness is measured.
Why is staging important?
Staging helps guide treatment decisions and gives information about survival chances.
What does 'M' in TNM stand for?
'M' stands for metastasis, indicating whether cancer has spread to other parts of the body.
What does the mitotic rate indicate?
The mitotic rate helps predict how quickly cancer cells are dividing and growing.
Wrapping Up
Understanding melanoma staging can be the key to informed discussions with your healthcare provider.
Additional References
- Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the Skin. In: AJCC Cancer Staging Manual: Eighth Edition, Amin MB (Ed), American Joint Committee on Cancer, Chicago 2017. p.563.
- Elmore JG, Elder DE, Barnhill RL, et al. Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual. JAMA Netw Open 2018; 1.
- Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.